Carol Wong

1.5k total citations · 2 hit papers
31 papers, 1.2k citations indexed

About

Carol Wong is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Carol Wong has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Carol Wong's work include Congenital gastrointestinal and neural anomalies (6 papers), CAR-T cell therapy research (5 papers) and Pelvic floor disorders treatments (4 papers). Carol Wong is often cited by papers focused on Congenital gastrointestinal and neural anomalies (6 papers), CAR-T cell therapy research (5 papers) and Pelvic floor disorders treatments (4 papers). Carol Wong collaborates with scholars based in Hong Kong, China and United States. Carol Wong's co-authors include Suzanne Spong, Kenneth E. Lipson, Bhy Chung, Kenneth Kak Yuen Wong, Paul Kwong Hang Tam, Kenneth K. Wong, Stephen J. Klaus, Griffin P. Rodgers, Nathaniel S. Linde and Ingrid Langsetmo and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Carol Wong

29 papers receiving 1.1k citations

Hit Papers

CTGF is a central mediato... 2012 2026 2016 2021 2012 2025 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
    2012 455 citations Kenneth E. Lipson, Carol Wong et al. PubMed profile →
  2. Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
    2025 42 citations Armin Ghobadi, Veronika Bachanová et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Wong Hong Kong 14 494 253 210 181 177 31 1.2k
Shu Sun Denmark 17 324 0.7× 140 0.6× 176 0.8× 117 0.6× 208 1.2× 45 1.2k
Kiyotaka Nagahama Japan 24 467 0.9× 168 0.7× 177 0.8× 370 2.0× 304 1.7× 83 1.4k
Yuanyu Hu Singapore 11 742 1.5× 223 0.9× 313 1.5× 143 0.8× 326 1.8× 14 1.3k
Yukinari Masuda Japan 21 579 1.2× 232 0.9× 138 0.7× 232 1.3× 384 2.2× 52 1.7k
Meiko Takahashi Japan 22 699 1.4× 150 0.6× 371 1.8× 141 0.8× 161 0.9× 46 1.7k
Takayuki Yamada Japan 23 809 1.6× 311 1.2× 422 2.0× 146 0.8× 244 1.4× 74 1.8k
Pilar Sandoval Spain 21 420 0.9× 495 2.0× 276 1.3× 156 0.9× 260 1.5× 37 1.4k
Peipei Guo China 10 590 1.2× 298 1.2× 193 0.9× 188 1.0× 255 1.4× 30 1.3k
Naoto Kubota Japan 14 573 1.2× 316 1.2× 336 1.6× 156 0.9× 190 1.1× 38 1.3k
Erik B. Friedrich Germany 18 598 1.2× 197 0.8× 220 1.0× 391 2.2× 120 0.7× 30 1.4k

Countries citing papers authored by Carol Wong

Since Specialization
Citations

This map shows the geographic impact of Carol Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Wong more than expected).

Fields of papers citing papers by Carol Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Wong. The network helps show where Carol Wong may publish in the future.

Co-authorship network of co-authors of Carol Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Wong. A scholar is included among the top collaborators of Carol Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Wong. Carol Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strati, Paolo, Januario E. Castro, Aaron M. Goodman, et al.. (2025). Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study. The Lancet Haematology. 12(7). e505–e515. 2 indexed citations
2.
Ghobadi, Armin, Veronika Bachanová, Krish Patel, et al.. (2025). Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial. The Lancet. 405(10473). 127–136. 42 indexed citations breakdown →
3.
4.
5.
Liu, Xuelai, et al.. (2023). Direct cellular reprogramming and transdifferentiation of fibroblasts on wound healing—Fantasy or reality?. Chronic Diseases and Translational Medicine. 9(3). 191–199. 4 indexed citations
6.
Wong, Carol & Kenneth Kak Yuen Wong. (2021). Meconium peritonitis: A 22-year review in a tertiary referral center. Journal of Pediatric Surgery. 57(8). 1504–1508. 3 indexed citations
7.
Wong, Carol, Bhy Chung, Paul Tam, & Kenneth K. Wong. (2019). Quality of life and defecative function 10 years or longer after posterior sagittal anorectoplasty and laparoscopic-assisted anorectal pull-through for anorectal malformation. Pediatric Surgery International. 36(3). 289–293. 11 indexed citations
8.
Wong, Kenneth K. & Carol Wong. (2017). A review of long-term outcome and quality of life of patients after Kasai operation surviving with native livers. Pediatric Surgery International. 33(12). 1283–1287. 14 indexed citations
9.
Hsu, Jacob Shujui, Man‐Ting So, Clara Sze-Man Tang, et al.. (2017). De novo mutations in Caudal Type Homeo Box transcription Factor 2 (CDX2) in patients with persistent cloaca. Human Molecular Genetics. 27(2). 351–358. 5 indexed citations
10.
Wong, Carol, Qiuming He, Huimin Xia, et al.. (2017). Stage specific requirement of platelet-derived growth factor receptor-α in embryonic development. PLoS ONE. 12(9). e0184473–e0184473. 16 indexed citations
11.
Chung, Bhy, Carol Wong, Kenneth Kak Yuen Wong, & Paul Kwong Hang Tam. (2017). Assessing the long term manometric outcomes in patients with previous laparoscopic anorectoplasty (LARP) and posterior sagittal anorectoplasty (PSARP). Journal of Pediatric Surgery. 53(10). 1933–1936. 16 indexed citations
12.
Wong, Carol, Shuguang Jin, Jie Chen, Paul Tam, & Kenneth K. Wong. (2016). Predictors for bowel resection and the presence of a pathological lead point for operated childhood intussusception: A multi-center study. Journal of Pediatric Surgery. 51(12). 1998–2000. 25 indexed citations
13.
Chung, Bhy, Carol Wong, Dkm Ip, Paul Kwong Hang Tam, & Kenneth Kak Yuen Wong. (2016). Is laparoscopic surgery better than open surgery for the repair of congenital duodenal obstruction? A review of the current evidences. Journal of Pediatric Surgery. 52(3). 498–503. 37 indexed citations
14.
Wong, Carol, Bhy Chung, Paul Tam, & Kenneth K. Wong. (2015). Laparoscopic versus open operation for perforated peptic ulcer in pediatric patients: A 10-year experience. Journal of Pediatric Surgery. 50(12). 2038–2040. 12 indexed citations
15.
Wong, Carol, et al.. (2014). The value of the 24-h delayed abdominal radiograph of barium enema in the diagnosis of Hirschsprung’s disease. Pediatric Surgery International. 31(1). 11–15. 9 indexed citations
16.
Leung, Ling, Carol Wong, Bhy Chung, Kenneth Kak Yuen Wong, & Paul Kwong Hang Tam. (2014). Laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease in infants. Pediatric Surgery International. 31(1). 83–88. 5 indexed citations
17.
Lipson, Kenneth E., et al.. (2012). CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. PubMed. 5(S1). S24–S24. 455 indexed citations breakdown →
18.
19.
Hsieh, Matthew M., Nathaniel S. Linde, Mark E. Metzger, et al.. (2007). HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood. 110(6). 2140–2147. 128 indexed citations
20.
Entwistle, Joycelyn, Shiwen Zhang, Baihua Yang, et al.. (1995). Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene. 163(2). 233–238. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu Sun Breakdown of academic impact, for papers by Kiyotaka Nagahama Breakdown of academic impact, for papers by Yuanyu Hu Breakdown of academic impact, for papers by Yukinari Masuda Breakdown of academic impact, for papers by Meiko Takahashi Breakdown of academic impact, for papers by Takayuki Yamada Breakdown of academic impact, for papers by Pilar Sandoval Breakdown of academic impact, for papers by Peipei Guo Breakdown of academic impact, for papers by Naoto Kubota Breakdown of academic impact, for papers by Erik B. Friedrich
Rankless by CCL
2026